The U.S. Food and Drug Administration (FDA) on Thursday approved a new option for patients to self-inject Argenx SE’s (NASDAQ:ARGX) Vyvgart Hytrulo with a prefilled syringe (efgartigimod alfa and ...
VYVGART, the first-in-class FcRn blocker, now offers three administration options, including self-injection with a prefilled syringe Self-injection provides gMG and CIDP patients with flexibility for ...
Previously, the treatment had only been supplied in a single-dose vial that required administration by a health care professional using a winged infusion set. The Food and Drug Administration (FDA) ...
Already thriving with a successful launch of infused Vyvgart and its subcutaneous follow-on Vyvgart Hytrulo to the tune of $2.2 billion in sales last year, argenx has scored FDA approval for a new ...
Morning Overview on MSN
The FDA approved the first weight-loss pill you swallow instead of inject.
Adults with obesity who dread weekly injections now have a new option: a daily pill. The FDA approved Foundayo, the brand ...
Dupixent comes in two forms: a prefilled pen and a prefilled syringe. The Dupixent pen has a hidden needle and automatically injects the drug. The Dupixent syringe has a visible needle and requires ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results